XENOGESIS LIMITED
Company number 07541784 · Monitor this company
The most recent accounts indicate this company is dormant and not trading.
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£823,187
Balance sheet as at 2016-03-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2011-02-24
- Registered office
- Discovery Building Biocity, Pennyfoot Street, Nottingham, United Kingdom, NG1 1GR
- Postcode
- NG1 1GR
- Capital
- 87 GBP
- Accounts category
- Dormant
- Charges
- 0 outstanding
Accounts
- Last made up to
- 2025-03-31
- Next due by
- 2026-12-31
- Financial year end
- 31 March
Confirmation statement
- Last statement dated
- 2026-02-24
- Next due by
- 2027-03-10
Nature of business (SIC)
- 99999 Dormant Company
Officers 6 current · 6 resigned
Group structure
Controlled by SYGNATURE DISCOVERY LIMITED — since 2020-09-22
From persons-with-significant-control filings on the public register.
Contact details
- Website
- xenogesis.co.uk
- Phone
- 01159415401
Sygnature Discovery are a leading integrated Drug Discovery CRO with expertise across a range of therapeutic and biological target classes.
Previous company names
| Name | Date changed |
|---|---|
| FULLY INTEGRATED PHARMA SOLUTIONS LIMITED | 2011-06-22 |
Among its peers
Top 5%
by shareholders' funds, of 1,072 similar companies in NG
Trading since 2011.
Competitors Nottingham
This company ranks 31 among dormant company in Nottingham.
The class of 2011
14%
of the 20,962 companies in this sector incorporated in 2011 are still active today; 85% have since been dissolved.
A fact about the year, not a forecast for this company.